Universal Biosensors acquiring hemostasis reference lab business
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Universal Biosensors Inc. is acquiring Lifelabs LP's hemostasis reference laboratory business to meet increased production demand.
Universal Biosensors manufactures Siemens Healthcare Diagnostics' Xprecia Stride test strips to diagnose potential heart attack-inducing blood clots.
Universal Biosensors did not disclose the terms of the acquisition.
